⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
SABSW News
Form 8-K
sec.gov
SABS
SABSW
SAB BIO Presents Additional Clinical and Mechanistic Data from SAB-142 Phase 1 Trial in Adult Patients with Established Autoimmune Type 1 Diabetes at IDS 2026
globenewswire.com
SABS
SABSW
SAB BIO to Present Additional Data Supporting the Unique Profile of SAB-142 at the 2026 Immunology of Diabetes Society Congress
globenewswire.com
SABS
SABSW
Form 8-K
sec.gov
SABS
SABSW
SAB BIO Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
globenewswire.com
SABS
SABSW
Form 8-K
sec.gov
SABSW
SABS
SAB BIO Announces Additional Phase 1 Data for SAB-142 in Adult Patients with Established Autoimmune Type 1 Diabetes
globenewswire.com
SABS
SABSW
SAB BIO to Participate in Upcoming Investor Conferences
globenewswire.com
SABS
SABSW
SAB BIO to Participate in Upcoming Investor Conferences
globenewswire.com
SABS
SABSW